Table 2

Evidence of subclinical gut inflammation, mucosal dysregulation or MRI evidence indicative of sacroiliitis in FDRs

FDRASCA IgAASCA IgGCBir1fCal (mcg/g)MRI findingsHLA-B27 status
Subject 2NegativeNegativeNegative109.4 (ULN)Minimal bone marrow oedema of right sacroiliac joint present solely on a single slice; not considered positivePositive
Subject 4NegativePositiveNegative<15.6 (Negative)Not presentNegative
Subject 6NegativeNegativeNegative<15.6 (Negative)Bilateral sacroiliitis with inflammatory bone marrow oedemaNegative
Subject 8PositivePositivePositive157.3 (ULN)Not presentNegative
Subject 11NegativeNegativePositive<15.6 (Negative)Not presentPositive
Subject 12NegativeNegativeNegative76.6 (Negative)Mild active right sacroiliitisPositive
Subject 15NegativeNegativePositive<15.6 (Negative)Not presentNegative
Subject 16NegativeNegativeNegativeNo sample availableSmall area of sclerosis of left sacroiliac jointNegative
Subject 18NegativeNegativePositive81 (Negative)Not presentNegative
Subject 20NegativeNegativePositive28 (Negative)Not presentNegative
Subject 27NegativeNegativePositive69.4 (Negative)Active sacroiliitis left inferior sacroiliac joint, subtle changes right sacroiliac joint suggest chronic changes related to sacroiliitis but no active inflammationPositive
Subject 28NegativeNegativeNegative137 (ULN)Advanced bilateral sacroiliitisPositive
  • ASCA, anti-Saccharomyces cerevisiae antibodies; CBir1, antiflagellin antibodies; fCal, faecal calprotectin; FDR, first-degree relative; HLA-B27, human leucocyte antigen B27; Ig, immunoglobulin; ULN, upper limit of normal.